http://www.amicusrx.com
Amicus Therapeutics, Inc. Company Intro
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Industry
Healthcare
Amicus Therapeutics, Inc. Headquaters
1 Cedar Brook Drive
Cranbury,08512
United States
Amicus Therapeutics, Inc. Share price
27 Oct 2020 01:39 GMT
$18.23
-0.25 (-1.35 %)
Amicus Therapeutics, Inc. Market cap
$4.852 B
WMC RANKING
2020
Amicus Therapeutics, Inc. # 31
BiotechnologyLatest Amicus Therapeutics, Inc. News
26 Oct 2020
Leukodystrophy Drug Market Expected to Witness High ...
... Company Limited, CHIESI Farmaceutici S.p.A, Orchard Therapeutics plc, ... Ltd, Sangamo Therapeutics, Amicus Therapeutics, Inc, Nextrials, Inc, Protalix ...
26 Oct 2020
It may be game changer for your Portfolio: GlaxoSmithKline plc (GSK), Amicus Therapeutics Inc. (FOLD)
Amicus Therapeutics Inc. (FOLD) shares on Friday's trading session, jumped 2.55 percent to see the stock exchange hands at $18.48 per unit. Lets a quick look ...
27 Oct 2020
Lysosomal Storage Diseases Therapeutics Market Demand 2020- Size, Share, Key Trends, Wireless Technology, Comprehensive Analysis, Healthcare Infrastructure, Business Opportunities, Challenges and Highest Growth Rate During Forecast Period
... Pfizer, Inc., Sanofi, BioMarin Pharmaceutical Inc., Actelion Ltd., Raptor Pharmaceutical Corp., Protalix Biotherapeutics Inc., and Amicus Therapeutics, Inc.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Amicus Therapeutics, Inc. | 3.29 | 2.41 | 1.44 | 0 | 0 | 0 | 2.88 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.31 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.32 | 26 | 0 | 0 | 97.51 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.26 | 7.19 | 100 | 0 | 0 | 90.89 |
Amicus Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Amicus Therapeutics, Inc. | $182,237 | $461,014 | $-356,388 | $4.852B | 31 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.467B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $53.956B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.394B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.779B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Amicus Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
